Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 1
R&D Momentum
64/100
Pipeline Velocity
32/100
Trial Completion Rate
100/100
Pipeline Concentration
50/100
Pipeline Freshness
57/100
Strategic Signals
Activity
Last 14 days
Satisfaction and Tolerability of Virtual Reality as a Distraction During Small-Bore Intercostal Chest Drain Insertion: The VR-STICH Randomized Controlled Trial
Safety And Efficacy Of 8 Hourly Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency ; A Prospective Pilot Study
A Pilot Randomized Controlled Trial Comparing Safety and Feasibility of Medical Thoracoscopy Using Single-use Flexible Bronchoscope Versus SemiRigid Pleuroscope Among Hospitalized Patients With Pleural Effusion (FLEXPLEUR2)
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)